Cardio,Cardiovascular News,Cardiologists,Medicines,Heart Health,EKG

* Internet Search Results

*** Search Filter: "HeartAttack"

How to Say “Hello” in Spanish | SpanishDictionary.com
Hola, ¿cómo estás? Hello, how are you? We use ¿cómo estás? when speaking to one person informally. Use ¿Cómo está? when speaking to one person formally and ¿Cómo están? when speaking to a group of people.

5 Ways to Say Hello in Spanish - wikiHow
How do you say “hello” in Spanish? Spanish language teacher Carlos Valverde Ochando says the basic greeting for "hello" is “Hola.” If you’re in a more formal setting, you might say, “Hola, buenas.” In a casual setting, you might say, “¿Qué haces?” which translates to “What are you up to?”

How to Say "Hello" | Spanish Lessons - YouTube
Just learning how to speak Spanish? Learn how to say "hello" in Espanol with this Spanish lesson for beginners. Unable to read transcription file …...more

9 Ways to Say ‘Hello’ in Spanish - Tell Me In Spanish
For that reason, in this article, we compiled 9 different ways to say ‘hello’ in Spanish. Although all of these expressions are very popular, you need to make sure that you apply them in the correct context and country.

How to say "hello" and "goodbye" in Spanish
You probably already know that "hello" in Spanish is "hola", right? But Spanish greetings and pleasantries don't stop there. Just like in English, there are a bunch of ways you can say "hi", "how are you?" and "goodbye", depending on the situation. We'll start with the greetings you'll probably see in a Spanish phrase book.

How to Say “Hello” in Spanish | Learn “Hola ... - YouTube
Want to say “hello” in Spanish? It’s simple: hola – a friendly greeting you can use almost anywhere, anytime! In this quick lesson, you’ll learn how to use hola in everyday Spanish conversations,...

How to Say Hello in Spanish: 27 Ways to Greet Like a Native
Learn hola, ¿qué onda, formal vs casual greetings, and regional phrases. Master how to say hello in Spanish naturally—not like a textbook.

How to Say Hello in Spanish: 25 Greetings & Customs (2026)
The most common way to say hello in Spanish is hola (pronounced OH-lah, with a silent H). Beyond that, Spanish speakers use time-of-day greetings like buenos días, buenas tardes, and buenas noches, plus dozens of casual and formal variations depending on the situation.

How to Say Hello in Spanish: Examples and How to Use Them | Parrot
Hola is the basic, universal hello in Spanish, used in all contexts (formal and informal, day and night). Beyond hola, Spanish has time-of-day greetings (buenos días, buenas tardes, buenas noches) and many regional informal greetings.

Spanish Greetings for Beginners: Hello, How Are You & More
Your first Spanish words: how to say hello, ask how are you, say thank you and what to say when you don't understand. Video lesson + free PDF and quiz.

* Latest OCD 101 News

*** News Filter: "HeartAttack"

‘When sirens sound, it feels like a heart attack’: anxiety cases surge amid war  Ynetnews
New research finds 5 genetic signatures shared by 14 psychiatric disorders  Harvard Gazette
Shingles vaccine may reduce dementia, heart disease risk by 50%  MedicalNewsToday
Luke Combs Says His OCD Causes Him to Fear He's 'About to Have a Heart Attack'  People.com
Marylake’s superior dies Jan. 8 after heart attack  Arkansas Catholic
Luke Combs Reveals He Had His Worst OCD Flare-Up In Years Ahead Of Australia & New Zealand Tour: “2 Days Before This Trip… It Was Not Ideal”  Whiskey Riff
Grey's Anatomy Recap: Change Of Heart — Plus: Chandra Wilson Reflects On The Bottle Episode's Lasting Aftermath  TVLine
Fresh Meat's Kimberley Nixon praised for sharing OCD struggles  Wales Online
Amelle Berrabah has OCD  Female First
Why MM Has A Panic Attack In The Boys Season 4, Episode 6  ScreenRant
Chicago Med Season 9 Episode 7 Recap: Step on a Crack and Break Your Mother’s Back  TV Fanatic

Common Cardiovascular Symptoms & Warning Signs

Chest Pain or Pressure (Angina) — Sensation of squeezing, fullness, or tightness in the center of the chest that may radiate to the jaw, neck, back, or arm.
Shortness of Breath (Dyspnea) — Difficulty breathing or feeling winded during routine activities, exertion, or while lying flat in bed.
Palpitations or Irregular Heartbeat — Sensations of a racing, fluttering, pounding, or skipping heart rate.
Unexplained Dizziness or Lightheadedness — Sudden feelings of faintness, loss of balance, or near-syncope linked to decreased blood flow to the brain.
Swelling in the Extremities (Edema) — Fluid retention causing notable swelling in the legs, ankles, feet, or abdomen.
Unusual Fatigue and Weakness — Persistent tiredness or exhaustion during simple daily tasks, often an early warning sign of heart failure.
Cold Sweats or Diaphoresis — Sudden onset of unexplained profuse sweating accompanied by chest discomfort or anxiety.
Cyanosis or Pale Skin Tone — A bluish or abnormally pale discoloration of the skin, lips, or nail beds due to poor oxygen circulation.
Persistent Coughing or Wheezing — Chronic cough producing white or pink blood-tinged mucus caused by fluid accumulation in the lungs.
Pain in the Extremities (Claudication) — Cramping or aching in the calves, thighs, or hips during walking, indicating peripheral artery disease.

Current Cardiovascular Treatments

Dual GIP/GLP-1 Receptor Agonists — Advanced metabolic agents like tirzepatide cut major adverse cardiovascular events, reduce systemic vascular inflammation, and improve heart failure outcomes.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation therapy replacing traditional radiofrequency ablation to treat atrial fibrillation with greater tissue selectivity and safety.
SGLT2 Inhibitor Therapy — Guideline-directed medical treatment (e.g., dapagliflozin, empagliflozin) initiated early to reduce hospitalizations and mortality across heart failure spectrums.
Targeted siRNA & Lipid Gene Therapy — Small interfering RNA injectables (like inclisiran) and gene-editing therapies (VERVE-102) providing long-term LDL-C reduction with single-dose schedules.
Transcatheter Valve Therapies (TAVR / TMVR) — Minimally invasive catheter interventions for replacing or repairing severe aortic, mitral, and tricuspid valve stenosis/regurgitation without open-heart surgery.
Aldosterone Synthase Inhibitors — Targeted hormonal pathway medications, such as baxdrostat, designed to treat treatment-resistant hypertension by lowering aldosterone production.
Left Bundle Branch Area Pacing (LBBAP) — Conduction system pacing delivering direct physiological resynchronization as a superior alternative to traditional cardiac resynchronization therapy.
Dual Endothelin Receptor Antagonists — Novel oral therapies like aprocitentan used in combination regimes to target resistant high blood pressure through specialized vascular pathways.
Targeted Anti-Inflammatory Agents — Low-dose colchicine and specialized anti-inflammatory protocols aimed directly at preventing plaque rupture and reducing residual cardiovascular risk.
Mechanical Decompression Systems — Endovascular venous balloon technology and advanced left ventricular assist devices designed to acutely unload intracardiac pressures during heart failure crises.

Key Milestones in Cardiovascular History

Discovery of Blood Circulation (1628) — William Harvey published De Motu Cordis, demonstrating for the first time that blood circulates continuously through the body pumped by the heart.
Invention of the Stethoscope (1816) — René Laennec invented the wooden stethoscope, allowing physicians to auscultate and diagnose internal cardiac sounds non-invasively.
First Human Electrocardiogram (1902) — Willem Einthoven developed the string galvanometer to record the electrical activity of the heart, inventing the modern ECG.
First Human Cardiac Catheterization (1929) — Werner Forssmann performed the first successful cardiac catheterization on himself, opening the path for modern interventional cardiology.
Launch of the Framingham Heart Study (1948) — A landmark long-term epidemiological study began, establishing major risk factors like high blood pressure, cholesterol, and smoking.
Development of the Cardiopulmonary Bypass (1953) — John Gibbon successfully used a heart-lung machine on a human patient, enabling modern open-heart surgery.
First Successful Human Heart Transplant (1967) — Dr. Christiaan Barnard performed the world's first human-to-human heart transplant in Cape Town, South Africa.
First Coronary Angioplasty (1977) — Andreas Grüntzig performed the first successful percutaneous transluminal coronary angioplasty (PTCA) to open blocked arteries.
Introduction of Coronary Stents (1986) — Ulrich Sigwart and Jacques Puel implanted the first coronary stent in a human heart to prevent artery restenosis.
First TAVR Procedure (2002) — Alain Cribier performed the first Transcatheter Aortic Valve Replacement, revolutionizing treatment for aortic stenosis without open-heart surgery.

Current Cardiovascular Research & Breakthroughs

Gene-Editing for Lipid Lowering — Advanced base-editing and RNA therapies (such as VERVE-102) show potential for permanently reducing LDL cholesterol with single-dose targeted gene inactivation.
AI-Driven Predictive Diagnostics — Deep learning algorithms now evaluate polygenic risk scores and real-time imaging data to predict cardiac events years before clinical symptoms appear.
Stem Cell Remuscularization — Regenerative cardiac cell therapies using stem-cell-derived cardiomyocytes aim to repair post-infarct scar tissue and restore contractile function.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation technology is transforming arrhythmia management by selectively isolating cardiac tissue with lower procedural risk.
Anti-Inflammatory Therapies — Target-specific anti-inflammatory drugs are being validated to reduce residual vascular risk and suppress ongoing atheroma plaque progression.
Transcatheter Valve Evolution (TMVR/TAVR) — Next-generation transcatheter systems are expanding treatment options for complex structural valve conditions without traditional open surgery.
Digital Twin Hemodynamic Modeling — Virtual patient-specific cardiac models integrate imaging and biomarkers to simulate interventional outcomes before execution.
Conduction System Pacing (LBBAP) — Left bundle branch area pacing is replacing traditional biventricular pacing to provide more natural physiological resynchronization.
Cardioprotective Metabolic Drugs — Broadening applications of SGLT2 inhibitors and GLP-1 receptor agonists demonstrate significant reductions in heart failure admissions and vascular events.
Novel Aldosterone Synthase Inhibitors — New drug classes like Baxdrostat provide target-specific control for resistant hypertension by directly modulating hormone pathways.